ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Final Issue Of 1988

December 9, 1988

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

Healthcare Utilization Figures More Than Biology In Disparity

April 30, 2010

Varmus Confirmation On Fast Track, Nominee Outlines Goals For Next Year

November 12, 1993

NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action

January 9, 2009

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

June 23, 2000